Blood Pressure and Risk of Secondary Cardiovascular Events in Women: The Women's Antioxidant Cardiovascular Study (WACS)

Circulation

Volumn 109, Issue 13, 2004, Pages 1623-1629

  Mason, Peter J ^a   Manson, JoAnn E ^a   Sesso, Howard D ^a   Albert, Christine M ^a   Chown, Marilyn J ^a   Cook, Nancy R ^a   Greenland, Philip ^a,b   Ridker, Paul M ^a   Glynn, Robert J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cardiovascular diseases; Hypertension; Prevention; Women

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; CYANOCOBALAMIN; FOLIC ACID ANTAGONIST; PYRIDOXINE; VITAMIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY RISK; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG USE; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSE PRESSURE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; STROKE; SYSTOLIC BLOOD PRESSURE; TRANSLUMINAL CORONARY ANGIOPLASTY; UNITED STATES;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COHORT STUDIES; DOUBLE-BLIND METHOD; FEMALE; FOLIC ACID; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; SYSTOLE; VITAMIN B 12; VITAMIN B 6;

EID: 1842559970     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000124488.06377.77     Document Type: Article

References (31)

1. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913.
2. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease, part 1: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765-774.
3. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA. 2003;289:2560-2572.
4. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens. 1999;17:151-183.
5. Whelton PK, He J, Appel LJ, et al. Primary prevention of hypertension: clinical and public heath advisory from the National Blood Pressure Education Program. JAMA. 2002;288:1882-1888.
6. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results for the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265:3255-3264.
7. Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial: risk factor changes and mortality results. JAMA. 1982;248:1465-1477.
8. O'Donnell CJ, Ridker PM, Glynn RJ, et al. Hypertension and borderline isolated systolic hypertension increase risks of cardiovascular disease and mortality in male physicians. Circulation. 1997;95:1132-1137.
9. Sesso HD, Stampfer MJ, Rosner B, et al. Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular risk in men. Hypertension. 2000;36:801-807.
10. Sagie A, Larson MG, Levy D. The natural history of borderline isolated systolic hypertension. N Engl J Med. 1993;329:1912-1917.
11. van den Hoogen PC, Feskens EJ, Nagelkerke NJ, et al. The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. N Engl J Med. 2000;342:1-8.
12. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342:145-153.
13. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033-1041.
14. Kannel WB, D'Agostino RB, Silbershatz H. Blood pressure and cardiovascular morbidity and mortality in the elderly. Am Heart J. 1997;134:758-763.
15. Port S, Demer L, Jennrich R, et al. Systolic blood pressure and mortality. Lancet. 2000;355:175-180.
16. D'Agostino RB, Belanger AJ, Kannel WB, et al. Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: the Framingham Study. BMJ. 1991;303:385-389.
17. Boutitie F, Gueyffier F, Pocock S, et al. J-Shaped relationship between blood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individual-patient data. Ann Intern Med. 2002;136:438-448.
18. Domanski M, Mitchell G, Pfeffer M, et al. Pulse pressure and cardiovascular disease-related mortality. JAMA. 2002;287:2677-2683.
19. Glynn RJ, Chae CU, Guralnik JM, et al. Pulse pressure and mortality in older people. Arch Intern Med. 2000;160:2765-2772.
20. Glynn RJ, L'Italien GJ, Sesso HD, et al. Development of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pressure. Hypertension. 2002;39:105-110.
21. Bassuk SS, Albert CM, Cook NR, et al. The Women's Antioxidant Cardiovascular Study: design and baseline characteristics of participants. J Womens Health. 2004;13:99-117.
22. Hu FB, Willett SC, Colditz GA, et al. Prospective study of snoring and risk of hypertension in women. Am J Epidemiol. 1999;150:806-816.
23. Klag MJ, He J, Mead LA, et al. Validity of physicians' self-reports of cardiovascular disease risk factors. Ann Epidemiol. 1993;3:442-447.
24. Colditz GA, Martin P, Stampfer MJ, et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol. 1986;123:894-900.
25. World Health Organization. Ischaemic Heart Disease Registers: Report of the Fifth Working Group (Including a Second Revision of the Operating Protocol): Copenhagen, 26-29 April 1971. Copenhagen, Denmark: Regional Office for Europe, World Health Organization; 1971.
26. Gould WW. Linear splines and piecewise linear functions. Stata Tech Bull. 1993;15:13-17.
27. Glynn RJ, Field TS, Rosner B, et al. Evidence for a positive linear relation between blood pressure and mortality in elderly people. Lancet. 1995;345:825-829.
28. Franklin SS, Gustin W, Wong ND, et al. Hemodynamic patterns of age-related changes in blood pressure: the Framingham Heart Study. Circulation. 1997;96:308-315.
29. Flack JM, Neaton J, Grim R, et al, for the Multiple Risk Factor Intervention Trial Research Group. Blood pressure and mortality among men with prior myocardial infarction. Circulation. 1995;92:2437-2445.
30. D'Agostino RB, Russell MW, Huse DH, et al. Primary and subsequent coronary risk appraisal: new results from the Framingham Study. Am Heart J. 2000;139:272-281.
31. Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA. 1996;275:1571-1576.